Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
Sign Up to like & getrecommendations! Published in 2023 at "Open Life Sciences"
DOI: 10.1515/biol-2022-0606
Abstract: Targeted therapy and PD - 1/L1 inhibitors are the main treat - ments for BRAF V600 - mutated melanomas [ 1,2 ] . Recently, PD - 1 inhibitors for melanoma with toripalimab have been developed… read more here.
Keywords: vemurafenib following; toripalimab combined; toripalimab; skin toxicity ... See more keywords